| 0 (0%) | 12-26 20:12 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.74 |
1-year : | 11.37 |
| Resists | First : | 8.34 |
Second : | 9.74 |
| Pivot price | 7.65 |
|||
| Supports | First : | 7.72 |
Second : | 7.34 |
| MAs | MA(5) : | 7.75 |
MA(20) : | 7.68 |
| MA(100) : | 8.42  |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 64.1 |
D(3) : | 52.2 |
| RSI | RSI(14): 56.4 |
|||
| 52-week | High : | 9.92 | Low : | 4.67 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ FENC ] has closed It is unclear right now based on current values. 48.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 8.11 - 8.14 | 8.14 - 8.16 |
| Low: | 7.51 - 7.55 | 7.55 - 7.58 |
| Close: | 8.03 - 8.09 | 8.09 - 8.14 |
Fri, 26 Dec 2025
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - The Manila Times
Fri, 26 Dec 2025
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - The Spec
Fri, 26 Dec 2025
Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Mon, 22 Dec 2025
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Sun, 21 Dec 2025
Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC) - Seeking Alpha
Sun, 21 Dec 2025
Craig-Hallum Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating - 富途牛牛
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 34 (M) |
| Shares Float | 20 (M) |
| Held by Insiders | 13.2 (%) |
| Held by Institutions | 46.9 (%) |
| Shares Short | 882 (K) |
| Shares Short P.Month | 981 (K) |
| EPS | -0.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.16 |
| Profit Margin | -17.9 % |
| Operating Margin | -1.6 % |
| Return on Assets (ttm) | -5.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 78.6 % |
| Gross Profit (p.s.) | 1.05 |
| Sales Per Share | 1.13 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -31.12 |
| PEG Ratio | 0 |
| Price to Book value | -50.57 |
| Price to Sales | 7.12 |
| Price to Cash Flow | -34.58 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|